BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34594418)

  • 1. Construction and validation of nomograms for non-metastatic Ewing sarcoma: A prognostic factor analysis based on the SEER database.
    Huang R; Han D; Shi C; Yan P; Hu P; Zhu X; Yin H; Meng T; Huang Z
    Oncol Lett; 2021 Nov; 22(5):777. PubMed ID: 34594418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the Prognosis Factors and Predicting the Survival Probability in Patients with Non-Metastatic Chondrosarcoma from the SEER Database.
    Huang R; Sun Z; Zheng H; Yan P; Hu P; Yin H; Zhang J; Meng T; Huang Z
    Orthop Surg; 2019 Oct; 11(5):801-810. PubMed ID: 31663279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A nomogram for predicting overall survival in patients with Ewing sarcoma: a SEER-based study.
    Zhou Z; Wang J; Fang L; Ma J; Guo M
    BMC Musculoskelet Disord; 2020 Nov; 21(1):737. PubMed ID: 33183244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Validation of Nomograms Predicting Overall and Cancer-Specific Survival of Spinal Chondrosarcoma Patients.
    Song K; Song J; Shi X; Wang H; Ma X; Xia X; Liang X; Lin K; Jiang J
    Spine (Phila Pa 1976); 2018 Nov; 43(21):E1281-E1289. PubMed ID: 29664813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.
    Song Z; Cheng L; Lu L; Lu W; Zhou Y; Wang Z
    Front Endocrinol (Lausanne); 2021; 12():764571. PubMed ID: 35308782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating and Predicting the Probability of Death in Patients with Non-Metastatic Osteosarcoma: A Population-Based Study.
    Huang R; Xian S; Shi T; Yan P; Hu P; Yin H; Meng T; Huang Z
    Med Sci Monit; 2019 Jun; 25():4675-4690. PubMed ID: 31231119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms predicting the overall survival and cancer-specific survival of patients with stage IIIC1 cervical cancer.
    Feng Y; Wang Y; Xie Y; Wu S; Li Y; Li M
    BMC Cancer; 2021 Apr; 21(1):450. PubMed ID: 33892663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nomograms and risk classification systems predicting overall and cancer-specific survival in primary malignant cardiac tumor.
    Guan T; Li Y; Qiu Z; Zhang Y; Lin W; Lai Y; Wang K; Shen Y; Du L; Liu C
    J Card Surg; 2019 Dec; 34(12):1540-1549. PubMed ID: 31794125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing a novel prognostic tool for Ewing sarcoma patients: Surveillance, Epidemiology, and End Results database analysis.
    Gao F; Zhou Y; Zhao R; Ren Y
    Medicine (Baltimore); 2020 Nov; 99(46):e23050. PubMed ID: 33181669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.
    Wang B; Chen LJ; Wang XY
    Orthop Surg; 2020 Dec; 12(6):1652-1662. PubMed ID: 32914587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomograms for predicting overall survival and cancer-specific survival in patients with surgically resected intrahepatic cholangiocarcinoma.
    Ma K; Dong B; Wang L; Zhao C; Fu Z; Che C; Liu W; Yang Z; Liang R
    Cancer Manag Res; 2019; 11():6907-6929. PubMed ID: 31440084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms for predicting the overall and cause-specific survival in patients with malignant peripheral nerve sheath tumor: a population-based study.
    Yan P; Huang R; Hu P; Liu F; Zhu X; Hu P; Yin H; Zhang J; Meng T; Huang Z
    J Neurooncol; 2019 Jul; 143(3):495-503. PubMed ID: 31089923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic nomograms for predicting overall and cancer-specific survival of high-grade osteosarcoma patients.
    Song K; Song J; Chen F; Lin K; Ma X; Jiang J
    J Bone Oncol; 2018 Nov; 13():106-113. PubMed ID: 30591864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of prognostic nomograms for patients with colon neuroendocrine neoplasms.
    Xu R; Zhou B; Hu P; Xue B; Gu D; Li X; Tang Q
    World J Surg Oncol; 2021 Aug; 19(1):233. PubMed ID: 34364382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nomograms individually predict the survival of patients with soft tissue sarcomas after surgery.
    Zhang SL; Wang ZM; Wang WR; Wang X; Zhou YH
    Cancer Manag Res; 2019; 11():3215-3225. PubMed ID: 31114361
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for metastasis and poor prognosis of Ewing sarcoma: a population based study.
    Shi J; Yang J; Ma X; Wang X
    J Orthop Surg Res; 2020 Mar; 15(1):88. PubMed ID: 32131863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomogram development and external validation for predicting overall survival and cancer-specific survival in patients with primary retroperitoneal sarcoma: a retrospective cohort study.
    Zheng J; Zhuang A; Xia X; Miao F; Wang Z; Kong X; Ren Y; Ma Y; Lin Z; Lu W; Li W
    Discov Oncol; 2023 Nov; 14(1):197. PubMed ID: 37910291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
    Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
    Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic nomograms based on log odds of positive lymph nodes for patients with renal cell carcinoma: A retrospective cohort study.
    Zhou W; Huang C; Yuan N
    Int J Surg; 2018 Dec; 60():28-40. PubMed ID: 30389534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.